37PDSNPS IN ANGIOGENIC FACTORS AS PREDICTIVE MARKERS FOR OUTCOME IN PATIENTS (P) WITH ADVANCED NON-SQUAMOUS NSCLC (NS-NSCLC) TREATED WITH CARBOPLATIN, PACLITAXEL (CP) AND BEVACIZUMAB (BEV). FINAL RESULTS OF ANGIOMET SPANISH LUNG CANCER GROUP TRIAL


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles